Skip to content

BioAdaptives Inc.: 10-Q filed 2023-11-13

What BioAdaptives Inc. reported in its quarterly report filed 2023-11-13 (fiscal Q3 2023): 29 published measures, 87 facts as tagged in accession 0001640334-23-002105.

This filing

Form
10-Q (quarterly report)
Filed
2023-11-13
Fiscal period
fiscal Q3 2023
Accession
0001640334-23-002105 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioAdaptives Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-30329,302USD
At 2022-12-3137,314USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-301,475,150USD
At 2022-12-311,488,815USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-30-1,145,848USD
At 2023-06-30-1,678,512USD
At 2023-03-31-1,630,652USD
At 2022-12-31-1,451,501USD
At 2022-09-30-1,595,858USD
At 2022-06-30-1,494,946USD
At 2022-03-31-1,398,153USD
At 2021-12-31-1,093,039USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-13,061USD92
2023-01-01 to 2023-09-30-444,165USD273
2023-04-01 to 2023-06-30-143,917USD91
2023-01-01 to 2023-03-31-287,187USD90
2022-07-01 to 2022-09-30-276,325USD92
2022-01-01 to 2022-09-30-867,293USD273
2022-04-01 to 2022-06-30-223,837USD91
2022-01-01 to 2022-03-31-367,131USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-132,477USD273
2022-01-01 to 2022-09-30-199,755USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-07-01 to 2023-09-3015,649USD92
2023-01-01 to 2023-09-3021,364USD273
2022-07-01 to 2022-09-303,337USD92
2022-01-01 to 2022-09-3013,192USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-30259,144USD273
2022-01-01 to 2022-09-30136,351USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-30-7,995,844USD
At 2022-12-31-7,551,679USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-30162,677USD
At 2022-12-3134,324USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-3020,625USD92
2023-01-01 to 2023-09-30123,941USD273
2022-07-01 to 2022-09-3094,106USD92
2022-01-01 to 2022-09-30199,572USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-301,475,150USD
At 2022-12-311,488,815USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-303,344USD
At 2022-12-310USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2023-09-30166,625USD
At 2022-12-312,990USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-3096,863USD92
2023-01-01 to 2023-09-30175,257USD273
2022-07-01 to 2022-09-3079,045USD92
2022-01-01 to 2022-09-30400,694USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-09-307,250USD
At 2022-12-318,877USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-304,650USD92
2023-01-01 to 2023-09-308,120USD273
2022-07-01 to 2022-09-302,000USD92
2022-01-01 to 2022-09-306,096USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-3010,999USD92
2023-01-01 to 2023-09-3013,244USD273
2022-07-01 to 2022-09-301,337USD92
2022-01-01 to 2022-09-307,096USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-30776,474,023shares
At 2022-12-31252,544,765shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-09-30152,072USD
At 2022-12-3125,405USD
At 2022-09-3019,532USD
At 2021-12-3182,936USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-306,771,839USD
At 2022-12-316,074,763USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2023-09-30126,294USD
At 2022-12-31100,919USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-444,165USD273
2022-01-01 to 2022-09-30-867,293USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-3033,706USD92
2023-01-01 to 2023-09-3060,258USD273
2022-07-01 to 2022-09-3043,981USD92
2022-01-01 to 2022-09-30236,698USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2023-07-01 to 2023-09-3037,643USD92
2023-01-01 to 2023-09-3038,989USD273
2022-07-01 to 2022-09-304,476USD92
2022-01-01 to 2022-09-3061,464USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2023-07-01 to 2023-09-3079,152USD92
2023-01-01 to 2023-09-30-277,028USD273
2022-07-01 to 2022-09-30-199,280USD92
2022-01-01 to 2022-09-30-472,695USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-304,728USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2023-01-01 to 2023-09-300USD273
2022-01-01 to 2022-09-300USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-09-30178,100USD273
2022-01-01 to 2022-09-301,623USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-301,627USD273
2022-01-01 to 2022-09-30-3,250USD273

Inspect the source

Entity
BioAdaptives Inc. / CIK 0001575142
Captured
2026-09-20T09:21:44.555Z
SEC response SHA-256
7d70ec2a8370eeb33cd7c2482065b30cf052619c39bb59e21df838c8d2f96db2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001575142.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))